← All companies

HKPD

Cellyan Biotechnology Co., Ltd

HKPD Nasdaq Wholesale-Drugs, Proprietaries & Druggists' Sundries EDGAR ↗

$0.41

+0.00 +0.39%

Key statistics

from XBRL data in SEC filings

Market cap

$4.51M

Revenue (TTM)

—

Net income (TTM)

—

EPS (TTM)

—

P/E ratio

—

Dividend yield

—

Free cash flow

—

Cash

—

Total assets

—

Gross margin

—

52-week range

$0.31 – $2.58

Recent SEC filings

40 most recent

Annual, quarterly & current reports

6-K REPORT OF FOREIGN PRIVATE ISSUER Jul 16, 2026 6-K REPORT OF FOREIGN PRIVATE ISSUER Mar 27, 2026 6-K REPORT OF FOREIGN PRIVATE ISSUER Mar 18, 2026 6-K REPORT OF FOREIGN PRIVATE ISSUER Jan 16, 2026 6-K REPORT OF FOREIGN PRIVATE ISSUER Dec 31, 2025 6-K REPORT OF FOREIGN PRIVATE ISSUER Dec 17, 2025 6-K CURRENT REPORT Nov 24, 2025 6-K REPORT OF FOREIGN PRIVATE ISSUER Nov 12, 2025 6-K REPORT OF FOREIGN PRIVATE ISSUER Oct 7, 2025 6-K REPORT OF FOREIGN PRIVATE ISSUER Sep 11, 2025 20-F ANNUAL REPORT Aug 14, 2025 6-K REPORT OF FOREIGN PRIVATE ISSUER Mar 28, 2025 6-K REPORT OF FOREIGN PRIVATE ISSUER Jan 17, 2025

Other filings

NT 20-F NOTIFICATION OF LATE FILING Jul 31, 2026 EFFECT Jun 24, 2026 F-3 REGISTRATION STATEMENT Jun 12, 2026 3 Jun 12, 2026 3 Jun 10, 2026 3 Jun 9, 2026 3 OWNERSHIP DOCUMENT Jun 8, 2026 3 OWNERSHIP DOCUMENT Jun 8, 2026 3 OWNERSHIP DOCUMENT Jun 8, 2026 3 OWNERSHIP DOCUMENT Jun 8, 2026 EFFECT Apr 8, 2026 CORRESP Apr 6, 2026 UPLOAD Apr 2, 2026 F-1 REGISTRATION STATEMENT Mar 27, 2026 SCHEDULE 13D Nov 12, 2025 NT 20-F NOTIFICATION OF LATE FILING Jul 31, 2025 SCHEDULE 13G Jun 5, 2025 SCHEDULE 13G Jun 5, 2025 SCHEDULE 13G Jun 3, 2025 424B4 PROSPECTUS Jan 15, 2025 CERT Jan 13, 2025 8-A12B FOR REGISTRATION OF CERTAIN CLASSES Jan 8, 2025 EFFECT Dec 20, 2024 CORRESP Dec 20, 2024 CORRESP Dec 20, 2024 CORRESP Dec 10, 2024 F-1/A AMENDMENT NO. 3 TO FORM F-1 Dec 10, 2024